Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Podcast Digital Health Today-Resources Digital Health Today Ambassadors

Digital Health Today 360°

S10: #097 : Robert Cohen, CTO at Stryker Joint Replacement, discusses robots, wearable sensors, and patient outcomes

Combining hardware and data to improve patient outcomes
February 11, 2020
S10: #097 : Robert Cohen, CTO at Stryker Joint Replacement, discusses robots, wearable sensors, and patient outcomes
Advertisement

Our guest:

In this episode, we speak with Robert Cohen, VP of Global R&D, Chief Technology Officer at Stryker Joint Replacement. Stryker is one of the world’s leading medical technology companies, and is leading the development of new ways to transform and enhance the technology available in musculoskeletal care.  

Robert shared some insights on the work Stryker is doing to improve surgical practice as well as capture more and better data about patient outcomes. We dive into the latest information about surgical robots, wearable sensors, and data, and explore the advances that may develop over the next 10 years.  

Links and Resources:

The Venue:

This conversation was recorded at DOCSF in January 2020, the weekend before #JPM Week in San Francisco. DOCSF is all about the intersection of digital health and musculoskeletal care.

This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and Dan Kendall interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here or visit Health Podcast Network.

Digital Health Today is made possible by the support of our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

cover
Coffee Talk: How Corporations Adapt in the Face of New Challenges Innovating at the speed of COVID-19. PLUS: Meet the new companies in the 2020 cohort of Bayer G4A
X
X